Ben Leyland
Senior Fund Manager
The JOHCM International Opportunities Fund is managed by Ben Leyland, senior fund manager, and Robert Lancastle, fund manager, supported by dedicated analyst Jasmeet Munday. The team seeks to generate high risk-adjusted returns with volatility below that of the broad market by focusing on high-quality, cash-flow-generative companies. They blend the best of quality investing with the best of value investing in order to avoid the two major sources of capital destruction at market turning points: overvaluation and overleverage. They prioritize businesses with strong franchises, strong balance sheets and the ability to create shareholder value by reinvesting in areas of competitive advantage, but they only commit capital where they see a favorable risk/reward ratio, i.e., limited downside and substantial upside on a 3- to 5-year horizon. They emphasize absolute rather than relative returns and are prepared to hold up to 20% cash in the fund when valuations are unattractive.
The team aims to deliver above-average risk-adjusted equity returns over the medium term. They believe this is best achieved by investing in a concentrated, unconstrained portfolio of attractively valued compound growth companies. They prioritize companies that are able to reliably generate cash flow and reinvest it at high marginal returns in order to grow their intrinsic value. As a result, the companies become more valuable over time.
The investment objective of the JOHCM International Opportunities Fund is to achieve long-term total return by investing in a concentrated portfolio of international equity securities. The Fund invests, under normal market conditions, primarily in equity securities of companies headquartered outside the U.S., including those in emerging markets. The Fund may invest in foreign companies of any size, including small- and mid-capitalization companies, in order to achieve its objective. Equity securities include common and preferred stocks, rights and warrants. The Fund may also invest in equity related instruments, such as equity linked notes and participation notes, all of which derive their value from equities. Equity linked notes and participation notes will be securitized, freely transferable and the Fund will not be leveraged as a result of investing in them. The portfolio typically contains 25 to 40 stocks,* with position sizes of 2% to 5%. The Fund is benchmarked against the MSCI EAFE Index, but their process is benchmark-agnostic: The team aims to cluster exposure around particularly attractive areas and have zero exposure to overleveraged or overvalued areas of the market. The process is biased toward larger-cap (>$5 billion) multinationals listed in developed markets.
*The number of stocks in the portfolio will be fewer than 50.
Senior Fund Manager
Senior Fund Manager
Analyst
Fund managers Christopher Lees and Nudgem Richyal believe stock markets are inefficient and aim to exploit market anomalies via an investment process that combines both top-down and bottom-up research. Their intuitive “4-Dimensional” investment process (stocks, sectors, countries, time/change) focuses on the be...
Read MoreFund size | $34.15mn | ||||||||
---|---|---|---|---|---|---|---|---|---|
Benchmark | MSCI EAFE Index | ||||||||
Share classes |
|
||||||||
Minimum investment |
|
||||||||
Fund codes |
|
||||||||
Fees and Expenses |
|
Morningstar Rating Rank |
|
---|
Investment Advisor | Perpetual Americas Funds Services |
---|---|
Transfer Agent | Northern Trust |
Custodian | Northern Trust |
Volatility increased in Q2 compared to Q1, with a dip in early April. However, by the quarter’s end, equity markets showed a return to narrow leadership. The ‘Mag-7’ remained prominent, but within the technology sector, there were significant subsector differences. Software and Services dropped 7% in the first two months and only recovered to a 2% decline for the quarter. In contrast, semiconductors and hardware surged by over 15% during the three months. Four mega-cap companies (all non-US) experienced gains exceeding 20% each in the quarter. These companies were responsible for nearly all market growth and now hold a dominant position. Additionally, twelve mega-cap companies (including the ‘Mag-7’ plus other major semiconductor firms and pharmaceutical players) represent a significant portion of the global market. Notably, the number of companies with a market capitalisation exceeding $1 trillion has doubled in under six years.
With little exposure to this group of stocks, the fund was negative during the quarter, outperforming the drawdown in April but lagging the tech-driven recovery.
When leadership is this narrow, it is easy to assume that there is only one way to deliver returns, and that requires you to get a handful of big thematic and macro calls right. We disagree - there are a lot of interesting things going on beyond AI, GLP-1s, inflation and interest rates. Since Covid, there has been an unusual lack of coordination between cycles, and this has created some real disconnects between valuations and fundamentals. Currently, there is a multitude of sectors worth monitoring closely, including traditionally stable areas such as staples (eg spirits) and healthcare (eg life sciences), as well as more classically cyclical areas like industrial automation and automotive semiconductors. By triangulating compounding potential, valuation and execution, our process allows us to recognise when these disconnects represent genuine opportunities and are likely todrive strong medium-term returns.
We added four new names to the portfolio towards the end of the quarter, such as the Australian insurer QBE and the Japanese electronics company Murata. Given we were already at our maximum of forty stocks, these were funded by the sale of Continental, Wartsila, Bankinter and Tokio Marine Holdings.
Sources for all data: JOHCM/Bloomberg (unless otherwise stated).
1 Month Total Return | 3 Month Total Return | YTD Total Return | 1 Year Total Return | Cumulative Since Inception | |
---|---|---|---|---|---|
Institutional Shares Net | 3.81 | 4.95 | 12.94 | 21.03 | 83.35 |
Benchmark | 3.25 | 4.56 | 11.96 | 19.40 | 76.88 |
1 Year | 2 Year | 3 Year | 4 Year | 5 Year | 10 Year | Annualized Since Inception | |
---|---|---|---|---|---|---|---|
Institutional Shares Net | 12.37 | 18.61 | 5.67 | 10.69 | 7.60 | 7.05 | |
Benchmark | 11.54 | 15.10 | 2.89 | 9.58 | 6.46 | 6.79 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annual | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fund | 2016 | -0.24 | -3.28 | -2.60 | 2.01 | -4.13 | ||||||||
Benchmark | 2016 | -0.29 | -2.05 | -1.99 | 3.42 | |||||||||
Fund | 2017 | 0.85 | 1.95 | 1.91 | 2.88 | 5.22 | -0.99 | 2.18 | 1.26 | 1.32 | 0.71 | -0.15 | -0.18 | 18.17 |
Benchmark | 2017 | 2.90 | 1.43 | 2.75 | 2.54 | 3.67 | -0.18 | 2.88 | -0.04 | 2.49 | 1.52 | 1.05 | 1.61 | 25.02 |
Fund | 2018 | 1.56 | -3.12 | 1.58 | 1.23 | -1.02 | -0.34 | 1.09 | -0.66 | 1.23 | -6.16 | 1.00 | -3.88 | -7.58 |
Benchmark | 2018 | 5.02 | -4.51 | -1.80 | 2.28 | -2.25 | -1.22 | 2.46 | -1.93 | 0.87 | -7.96 | -0.13 | -4.85 | -13.79 |
Fund | 2019 | 5.08 | 2.00 | 1.63 | 2.83 | -4.76 | 5.27 | -2.07 | -0.74 | 1.93 | 2.75 | 0.40 | 2.92 | 18.15 |
Benchmark | 2019 | 6.57 | 2.55 | 0.63 | 2.81 | -4.80 | 5.93 | -1.27 | -2.59 | 2.87 | 3.59 | 1.13 | 3.25 | 22.01 |
Fund | 2020 | -0.92 | -6.55 | -11.34 | 3.46 | 5.38 | 2.02 | 4.34 | 2.42 | -2.90 | -4.26 | 15.23 | 3.50 | 8.20 |
Benchmark | 2020 | -2.09 | -9.04 | -13.35 | 6.46 | 4.35 | 3.40 | 2.33 | 5.14 | -2.60 | -3.99 | 15.50 | 4.65 | 7.82 |
Fund | 2021 | -1.67 | 1.78 | 2.54 | 4.30 | 2.35 | -1.98 | -0.20 | 0.11 | -5.77 | 2.16 | -6.63 | 5.79 | 2.02 |
Benchmark | 2021 | -1.07 | 2.24 | 2.30 | 3.01 | 3.59 | -1.44 | 0.75 | 1.76 | -2.90 | 2.46 | -4.65 | 5.12 | 11.26 |
Fund | 2022 | 0.11 | -0.83 | -3.04 | -1.97 | 2.22 | -8.45 | 6.10 | -5.49 | -8.09 | 7.25 | 12.79 | 0.99 | -0.59 |
Benchmark | 2022 | -4.83 | -1.77 | 0.64 | -6.47 | 0.75 | -9.28 | 4.98 | -4.75 | -9.35 | 5.38 | 11.26 | 0.08 | -14.45 |
Fund | 2023 | 7.54 | -1.68 | 2.00 | 2.05 | -4.11 | 5.33 | 2.80 | -2.37 | -2.25 | -3.13 | 7.71 | 5.07 | 19.54 |
Benchmark | 2023 | 8.10 | -2.09 | 2.48 | 2.82 | -4.23 | 4.55 | 3.24 | -3.83 | -3.42 | -4.05 | 9.28 | 5.31 | 18.24 |
Fund | 2024 | -0.25 | 3.39 | 2.95 | -2.39 | 3.84 | -2.91 | 4.13 | 8.80 | |||||
Benchmark | 2024 | 0.58 | 1.83 | 3.29 | -2.56 | 7.07 | -1.61 | 2.93 | 8.43 |
Share Class | Gross Expense* | Net Expense* |
---|---|---|
Institutional | 4.20% | 0.50% |
The performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. The Fund's current performance may be lower or higher than the performance data quoted. Investors may obtain performance information current to the most recent month-end, within 7 business days at www.johcm.com or by calling 866-260-9549 or 312-557-5913.
Returns shown, unless otherwise indicated, are total returns, with dividends and income reinvested. Returns for periods of less than one year are not annualized. Fee waivers are in effect; if they had not been in effect performance would have been lower.
The MSCI EAFE Index (Europe, Australasia, Far East) is a free float-adjusted market capitalization index that is designed to measure the equity market performance of developed markets, excluding the US & Canada. Any Indicies mentioned are unmanaged statistical composites of stock market performance. Investing in an index is not possible.
*Expense ratios as stated in the latest prospectus. Perpetual Americas Funds Services has contractually agreed to waive fees and reimburse expenses so that the Net Total Operating Expenses do not exceed the stated amounts until February 1, 2026.
Merck KGaA | 4.11% |
Deutsche Bérse | 4.07% |
Compass Group | 3.77% |
Shellé | 3.77% |
Intact | 3.62% |
Sanofi | 3.45% |
CRH | 3.43% |
Roche | 3.31% |
Philip Morris International | 3.28% |
Daifuku | 2.99% |
Merck KGaA | +3.96% |
Deutsche Börse | +3.83% |
Intact | +3.62% |
Compass Group | +3.47% |
CRH | +3.43% |
Philip Morris International | +3.28% |
Daifuku | +2.95% |
Nitori | +2.84% |
Sanofi | +2.72% |
SoftBank Group | +2.61% |
Portfolio | Benchmark | Relative | ||
---|---|---|---|---|
Australia | 2.69% | 7.47% | -4.78% | |
Canada | 9.00% | 0% | 9% | |
France | 15.10% | 11.3% | 3.8% | |
Germany | 12.29% | 8.75% | 3.53% | |
Ireland | 3.43% | 0.29% | 3.13% | |
Japan | 17.89% | 22.78% | -4.89% | |
Sweden | 3.92% | 3.27% | 0.65% | |
Switzerland | 5.80% | 10.07% | -4.26% | |
United Kingdom | 17.17% | 14.82% | 2.34% | |
United States | 5.18% | 0% | 5.18% | |
Cash | 0.28% | 0% | 0.28% |
Portfolio | Benchmark | Relative | ||
---|---|---|---|---|
Financials | 18.76% | 20.40% | -1.60% | |
Industrials | 17.50% | 17.02% | 0.50% | |
Consumer Discretionary | 13.11% | 10.97% | 2.10% | |
Consumer Staples | 12.17% | 8.69% | 3.50% | |
Health Care | 10.88% | 14.23% | -3.30% | |
Energy | 8.57% | 3.86% | 4.70% | |
Information Technology | 6.34% | 8.92% | -2.60% | |
Communication Services | 5.53% | 4.22% | 1.30% | |
Materials | 4.32% | 6.44% | -2.10% | |
Utilities | 2.48% | 3.31% | -0.80% | |
Real Estate | 0.00% | 1.89% | -1.90% | |
Cash | 0.28% | 0.00% | 0.28% |
Portfolio | Benchmark | Relative | ||
---|---|---|---|---|
<10BN | 9.53% | 7.34% | 2.19% | |
>10BN | 88.38% | 92.66% | -4.28% |
Fund |
As at noon | Share class | Currency | CUSIP Number | NAV | Change | Change % | Previous | |
JOHCM International Select Fund | 19/09/2024 | Institutional | USD | 46653M849 | 25.23 | 0.43 | 1.73% | 24.80 | |
Investor | USD | 46653M823 | 25.27 | 0.44 | 1.77% | 24.83 | |||
JOHCM Emerging Markets Opportunities Fund | 19/09/2024 | Advisor | USD | 46653M203 | 11.66 | 0.17 | 1.48% | 11.49 | |
Institutional | USD | 46653M104 | 11.69 | 0.17 | 1.48% | 11.52 | |||
Investor | USD | 46653M302 | 11.64 | 0.17 | 1.48% | 11.47 | |||
JOHCM Global Select Fund | 19/09/2024 | Advisor | USD | 46653M807 | 14.61 | 0.25 | 1.74% | 14.36 | |
Institutional | USD | 46653M708 | 14.65 | 0.25 | 1.74% | 14.40 | |||
JOHCM Emerging Markets Discovery Fund | 19/09/2024 | Advisor | USD | 46653M500 | 15.03 | 0.16 | 1.08% | 14.87 | |
Institutional | USD | 46653M401 | 15.02 | 0.16 | 1.08% | 14.86 | |||
JOHCM International Opportunities Fund | 19/09/2024 | Institutional | USD | 46653M872 | 13.38 | 0.20 | 1.52% | 13.18 | |
Regnan Global Equity Impact Solutions | 19/09/2024 | Institutional | USD | 46653M716 | 7.47 | 0.13 | 1.77% | 7.34 | |
TSW Large Cap Value Fund | 19/09/2024 | Institutional | USD | 46653M641 | 14.01 | 0.07 | 0.50% | 13.94 | |
TSW Emerging Markets Fund | 19/09/2024 | Institutional | USD | 46653M666 | 9.53 | 0.11 | 1.17% | 9.42 | |
TSW High Yield Bond Fund | 19/09/2024 | Institutional | USD | 46653M658 | 9.35 | 0.01 | 0.11% | 9.34 |
The performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. The Fund's current performance may be lower or higher than the performance data quoted. Investors may obtain performance information current to the most recent month-end, within 7 business days at www.johcm.com or by calling 866-260-9549 or 312-557-5913.
Returns shown, unless otherwise indicated, are total returns, with dividends and income reinvested. Returns for periods of less than one year are not annualized. Fee waivers are in effect; if they had not been in effect performance would have been lower.
The MSCI EAFE Index (Europe, Australasia, Far East) is a free float-adjusted market capitalization index that is designed to measure the equity market performance of developed markets, excluding the US & Canada. Any Indicies mentioned are unmanaged statistical composites of stock market performance. Investing in an index is not possible.
*Expense ratios as stated in the latest prospectus. Perpetual Americas Funds Services has contractually agreed to waive fees and reimburse expenses so that the Net Total Operating Expenses do not exceed the stated amounts until February 1, 2026.
After years of tech dominance in the U.S. equity market, a return to fundamentals is pushing new growth opportunities into fruition.
Opportunities and Challenges in the International Investing Landscape
Despite demographic challenges, there are unique opportunities within the Japanese equity market.
A number of capital cycles are turning. We believe investors need to shift their focus towards sectors which have been overlooked.
For a better experience, we recommend viewing this website in landscape orientation.